| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5830635 | European Journal of Pharmacology | 2009 | 7 Pages |
Abstract
Results suggest that telmisartan may reduce type-I diabetes mellitus-induced hepatic injury by suppressing activated hepatic stellate cells through concomitant TGF-β1 down-regulation.
Related Topics
Life Sciences
Neuroscience
Cellular and Molecular Neuroscience
Authors
Zekai Halici, Habip Bilen, Fatih Albayrak, Abdullah Uyanik, Ramazan Cetinkaya, Halis Suleyman, Osman Nuri Keles, Bunyami Unal,